MarketCap
Facebook
X
Telegram
Country |
 USA |
IPO year |
1989 |
Industry |
Diagnostics research |
Stock Exchange |
NASDAQ GLOBALSPB |
Shares |
218 M |
Market Cap[1] |
$ 2.59 B |
EBITDA (LTM) |
$ 94.7 M |
P/E (LTM) |
-39.433333 |
P/S (LTM) |
2.951455 |
EPS (LTM) |
-0.3 |
Other stocks of industry "Diagnostics research"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
 |
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market |  Canada |
 |
IDEXX Laboratories
IDXX
|
$ 523.55 | 1.15 % | $ 42.1 B | Nasdaq Global Select Market,SPB | USA |
 |
Illumina
ILMN
|
$ 215.12 | 3.94 % | $ 33.3 B | Nasdaq Global Select Market,SPB | USA |
 |
IQVIA Holdings
IQV
|
$ 262.27 | 2.95 % | $ 45.1 B | NYSE,SPB | USA |
 |
Lantheus Holdings
LNTH
|
$ 100.77 | 0.01 % | $ 6.8 B | Nasdaq Global Select Market,SPB | USA |
 |
Medpace Holdings
MEDP
|
$ 589.29 | 0.31 % | $ 17 B | Nasdaq Global Select Market,SPB | USA |
 |
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | USA |
 |
Mettler-Toledo International
MTD
|
$ 1 330.56 | 0.11 % | $ 27.4 B | NYSE,SPB |  Schweiz |
 |
Myriad Genetics
MYGN
|
$ 3.19 | 1.57 % | $ 295 M | Nasdaq Global Select Market,SPB | USA |
 |
ENDRA Life Sciences
NDRA
|
$ 6.0 | 0.83 % | $ 4.72 M | Nasdaq Global Select Market | USA |
 |
NeoGenomics
NEO
|
$ 17.57 | 1.09 % | $ 2.25 B | Nasdaq Global Select Market,SPB | USA |
 |
National Research Corporation
NRC
|
$ 20.81 | 1.32 % | $ 466 M | Nasdaq Global Select Market | USA |
 |
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | USA |
 |
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | USA |
 |
Heska Corporation
HSKA
|
- | - | $ 1.31 B | Nasdaq Capital Market,SPB | USA |
 |
HTG Molecular Diagnostics
HTGM
|
- | -20.0 % | $ 1.06 M | Nasdaq Capital Market | USA |
 |
Natera
NTRA
|
$ 327.95 | 0.16 % | $ 44.8 B | Nasdaq Global Select Market,SPB | USA |
 |
Psychemedics Corporation
PMD
|
- | -1.84 % | $ 15.3 M | Nasdaq Global Select Market | USA |
 |
Quotient Limited
QTNT
|
- | -11.32 % | $ 1.1 M | Nasdaq Global Select Market | Schweiz |
 |
Syneos Health
SYNH
|
- | - | $ 4.46 B | Nasdaq Global Select Market,SPB | USA |
 |
T2 Biosystems
TTOO
|
- | -39.35 % | $ 313 K | Nasdaq Global Select Market | USA |
 |
Meridian Bioscience
VIVO
|
- | - | $ 1.49 B | Nasdaq Global Select Market | USA |
 |
Anixa Biosciences
ANIX
|
$ 2.97 | 0.66 % | $ 96.4 K | Nasdaq Capital Market | USA |
|
Biodesix
BDSX
|
$ 27.42 | 4.72 % | $ 207 M | Nasdaq Global Market | USA |
 |
Biomerica
BMRA
|
$ 2.32 | 0.39 % | $ 6.76 M | Nasdaq Capital Market | USA |
 |
Quidel Corporation
QDEL
|
$ 13.25 | 0.29 % | $ 558 M | Nasdaq Global Select Market,SPB | USA |
 |
Precipio
PRPO
|
$ 26.53 | 4.9 % | $ 42.6 M | Nasdaq Global Select Market | USA |
 |
Personalis
PSNL
|
$ 16.86 | 2.2 % | $ 1.5 B | Nasdaq Global Select Market | USA |
 |
RadNet
RDNT
|
$ 73.02 | 0.24 % | $ 5.49 B | Nasdaq Global Select Market | USA |
 |
Senseonics Holdings
SENS
|
$ 9.36 | 5.97 % | $ 391 M | NYSE American | USA |
 |
Neuronetics
STIM
|
$ 2.87 | 5.88 % | $ 189 M | Nasdaq Global Select Market | USA |
 |
Thermo Fisher Scientific
TMO
|
$ 602.9 | 0.02 % | $ 227 B | NYSE,SPB | USA |
 |
Trinity Biotech plc
TRIB
|
$ 9.04 | 0.64 % | $ 3.25 B | Nasdaq Global Select Market |  Irlanda |
 |
Twist Bioscience Corporation
TWST
|
$ 126.69 | 1.58 % | $ 7.58 B | Nasdaq Global Select Market,SPB | USA |
 |
Sotera Health Company
SHC
|
$ 18.73 | 0.05 % | $ 5.32 B | Nasdaq Global Select Market | USA |
 |
VolitionRx Limited
VNRX
|
$ 0.34 | 2.52 % | $ 42.8 M | NYSE American |  Singapore |
 |
Waters Corporation
WAT
|
$ 402.5 | 0.33 % | $ 24 B | NYSE,SPB | USA |
 |
Exagen
XGN
|
$ 7.44 | 0.53 % | $ 160 M | Nasdaq Global Market | USA |
 |
DarioHealth Corp.
DRIO
|
$ 7.01 | 3.72 % | $ 27.9 M | Nasdaq Capital Market |  Israel |
 |
Agilent Technologies
A
|
$ 146.81 | 0.59 % | $ 41.7 B | NYSE,SPB | USA |
 |
BioNano Genomics
BNGO
|
$ 1.2 | 0.39 % | $ 6.53 M | Nasdaq Capital Market,SPB | USA |
 |
Co-Diagnostics
CODX
|
$ 1.13 | 2.55 % | $ 1.5 M | Nasdaq Capital Market | USA |
 |
Castle Biosciences
CSTL
|
$ 32.77 | 1.03 % | $ 950 M | Nasdaq Global Market,SPB | USA |
 |
Quest Diagnostics Incorporated
DGX
|
$ 235.53 | 2.07 % | $ 26.1 B | NYSE,SPB | USA |
 |
Danaher Corporation
DHR
|
$ 205.39 | 0.53 % | $ 146 B | NYSE,SPB | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
- | - | $ 562 M | Nasdaq Global Select Market |  Britain |
 |
CareDx, Inc
CDNA
|
$ 49.76 | 2.05 % | $ 2.65 B | Nasdaq Global Market,SPB | USA |
 |
ICON Public Limited Company
ICLR
|
$ 160.6 | 0.78 % | $ 12.6 B | Nasdaq Global Select Market,SPB | Irlanda |
 |
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | USA |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.